Operator of a mental health and wellness clinic intended to offer a wide range of treatments and healthcare services. The company reinvents mental healthcare through its network of clinics and offers patient profiles, a database of scientific research, analysis of vital information including genetic profile, comprehensive symptom profile, and brain-chemical balance estimates, thereby enabling patients…

The company is currently operating in Stealth mode.

The company creates a class of peptides capable of delivering CRISPR enzymes into clinically-relevant and previously untransfectable cell types, enabling clients to get CRISPR therapies.

Cytoscient offers expert services for pharmaceutical and biomarker development. Their goal is to provide high quality data that is cost-effective and rapid for your decision making. Their extensive experience includes early drug discovery, IND-enabling toxicology, and clinical trials. They know how to characterize new drug candidates, and to confidently translate results at each development stage.

Developer of biotechnological techniques designed to help women become biological parents at any point in life. The company focuses on complex human and mouse tissue culture techniques, including three-dimensional organoid culture, imaging, and analytics to eliminate the maternal age fertility barrier and allow same-sex couples to have biological children, enabling couples with fertility problems to…

Developer of therapeutic drugs intended for the treatment of acute bleeding and related indications. The company’s drugs offer an optimized, proprietary rFVIIa molecule, termed CT-001, for the prevention and treatment of acute bleeding and other coagulation cascade-related diseases and leverages expertise in biologics and the coagulation cascade to develop novel therapeutics targeted to treat acute…

Developer of an advanced protein coupling technology intended to cure autoimmune disorders. The company’s technology allows the attachment of any two proteins together faster and more selectively than any competing method by attaching the natural amino acids tyrosine and cysteine, helping clients in the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.